Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital diary aims to decode painful flares in spine condition

NCT ID NCT07688174

Knowledge-focused Sponsor: Royal United Hospitals Bath NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study investigates how people with axial spondyloarthritis (axSpA) experience sudden worsening of symptoms, known as flares. Over 12 months, 40 participants use a digital diary to track symptoms, diet, lifestyle, and self-management strategies, and provide blood samples during and between flares. The goal is to map different flare patterns and develop a patient-led digital pathway for earlier and more effective flare management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a digital tool that helps people with axSpA recognize and manage flares earlier, reducing their impact on daily life.
What could go wrong
This is an observational study with only 40 participants, so findings may not apply to everyone with axSpA. The pathway will need further testing before it can be widely used.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with axSpA will be recruited from two study sites (RUH and KCH), whilst the RUH (Bath) patient population has limited ethnic and sociodemographic diversity. However, KCH (London) serves a more diverse population of patients.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years) with a diagnosis of axSpA (non-radiographic or radiographic axSpA). * Access to an email address and electronic device, to participate in data collection. * Capacity to provide informed consent. * Sufficient communicative ability to participate in the research study (must be able to communicate in English). * Patient has experienced at least one (self-reported) flare in the 12-months prior to enrolment. Exclusion Criteria: * Patients \<18 years of age. * Patients with another diagnosis of inflammatory arthritis that is not axial spondyloarthritis. * Living with significant psychiatric morbidity, or if participation may cause distress. * Patient has participated in Project Nightingale (RUH only, 2018 - 2022).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Axial spondylarthritis (R-axspa) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis Axial Spondyloarthritis Non-Radiographic Axial Spondyloarthritis spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Axial spondylarthritis (R-axspa) Axial spondyloarthritis (axspa) Axial spondyloarthritis, non-radiographic Axial spondyloarthritis, radiographic

Contacts and locations

Locations

  • King's College Hospital NHS Foundation Trust

    London, SE5 9RS, United Kingdom

  • Royal United Hospitals Bath NHS Foundation Trust

    Bath, BA1 3NG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.